Keros Therapeutics, Inc.KROSNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Diluted earnings per share

Latest
2.30
↑ 197% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-2.38
Historical baseline
PeriodValueYoY Change
TTM2.30+146.0%
2024-5.00+3.8%
2023-5.20-25.3%
2022-4.15-64.7%
2021-2.52+14.0%
2020-2.93-110.8%
2019-1.39-826.7%
2018-0.15-